🇺🇸 Regional Anesthesia in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Caesarean Section — 2 reports (16.67%)
  2. Drug Exposure During Pregnancy — 2 reports (16.67%)
  3. Apgar Score Low — 1 report (8.33%)
  4. Body Temperature Increased — 1 report (8.33%)
  5. Foetal Heart Rate Deceleration — 1 report (8.33%)
  6. No Therapeutic Response — 1 report (8.33%)
  7. Nystagmus — 1 report (8.33%)
  8. Placental Infarction — 1 report (8.33%)
  9. Post Procedural Haemorrhage — 1 report (8.33%)
  10. Tachycardia Foetal — 1 report (8.33%)

Source database →

Regional Anesthesia in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Regional Anesthesia approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Regional Anesthesia in United States?

University of Florida is the originator. The local marketing authorisation holder may differ — check the official source linked above.